Vimarsana
Biggest News Aggregation in the World

Chris Loose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chris Loose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chris Loose Today - Breaking & Trending Today

Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases - Vimarsana News

Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases

Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today announced its launch and the closing of a $65...

Progentos Therapeutics Closes $65M Series A Financing - Vimarsana News

Progentos Therapeutics Closes $65M Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Forbion-backed biotech Progentos debuts with $65M for MS drug - Vimarsana News

Forbion-backed biotech Progentos debuts with $65M for MS drug

BioPharma

Frequency to cut jobs after clinical trial setback - Vimarsana News

Frequency to cut jobs after clinical trial setback

BioPharma

Hearing loss treatment scrapped as drug company announces 'disappointing results' - Vimarsana News

Hearing loss treatment scrapped as drug company announces 'disappointing results'

Frequency Therapeutics announced it will scrap development of a drug called FX-322 after testing failed to show improvement in speech perception in people with noise-induced sensorineural hearing loss.

Source: upi.com